$CRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Get notifications about new insider transactions in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for free.
Page: < prev 1 ... 49 50 51 52 53 54 55 56 57 ... 63 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Payment of Exercise | F | 24.80 | 282 | 6,994 | 81,607 | 81.9 K to 81.6 K (-0.34 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Grant | A | 0.00 | 1,775 | 0 | 81,889 | 80.1 K to 81.9 K (+2.22 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Payment of Exercise | F | 24.80 | 727 | 18,030 | 80,114 | 80.8 K to 80.1 K (-0.90 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Payment of Exercise | F | 24.80 | 1,023 | 25,370 | 80,841 | 81.9 K to 80.8 K (-1.25 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Grant | A | 0.00 | 4,000 | 0 | 81,864 | 77.9 K to 81.9 K (+5.14 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Grant | A | 0.00 | 17,250 | 0 | 77,864 | 60.6 K to 77.9 K (+28.46 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Option Exercise | A | 24.80 | 44,450 | 1,102,360 | 44,450 | |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Payment of Exercise | F | 24.80 | 235 | 5,828 | 60,757 | 61 K to 60.8 K (-0.39 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Payment of Exercise | F | 24.80 | 645 | 15,996 | 60,992 | 61.6 K to 61 K (-1.05 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Payment of Exercise | F | 24.80 | 974 | 24,155 | 61,637 | 62.6 K to 61.6 K (-1.56 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Grant | A | 0.00 | 1,775 | 0 | 62,611 | 60.8 K to 62.6 K (+2.92 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Grant | A | 0.00 | 11,250 | 0 | 60,836 | 49.6 K to 60.8 K (+22.69 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Option Exercise | A | 24.80 | 213,250 | 5,288,600 | 213,250 | |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Payment of Exercise | F | 24.80 | 2,124 | 52,675 | 292,023 | 294.1 K to 292 K (-0.72 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Payment of Exercise | F | 24.80 | 2,933 | 72,738 | 294,147 | 297.1 K to 294.1 K (-0.99 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Payment of Exercise | F | 24.80 | 5,010 | 124,248 | 297,080 | 302.1 K to 297.1 K (-1.66 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Grant | A | 0.00 | 10,175 | 0 | 302,090 | 291.9 K to 302.1 K (+3.49 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Grant | A | 0.00 | 54,000 | 0 | 291,915 | 237.9 K to 291.9 K (+22.70 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Option Exercise | A | 24.80 | 39,500 | 979,600 | 39,500 | |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Payment of Exercise | F | 24.80 | 80 | 1,984 | 26,043 | 26.1 K to 26 K (-0.31 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Payment of Exercise | F | 24.80 | 191 | 4,737 | 26,123 | 26.3 K to 26.1 K (-0.73 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Payment of Exercise | F | 24.80 | 104 | 2,579 | 26,314 | 26.4 K to 26.3 K (-0.39 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Grant | A | 0.00 | 500 | 0 | 26,418 | 25.9 K to 26.4 K (+1.93 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Grant | A | 0.00 | 10,000 | 0 | 25,918 | 15.9 K to 25.9 K (+62.82 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 24.80 | 68,150 | 1,690,120 | 68,150 | |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 981 | 24,329 | 91,770 | 92.8 K to 91.8 K (-1.06 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 727 | 18,030 | 92,751 | 93.5 K to 92.8 K (-0.78 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 877 | 21,750 | 93,478 | 94.4 K to 93.5 K (-0.93 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 6,177 | 0 | 94,355 | 88.2 K to 94.4 K (+7.01 %) |
| Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 17,250 | 0 | 88,178 | 70.9 K to 88.2 K (+24.32 %) |
| Feb 25 2009 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Payment of Exercise | F | 26.30 | 787 | 20,698 | 49,586 | 50.4 K to 49.6 K (-1.56 %) |
| Feb 24 2009 | CRL | CHARLES RIVER LABO ... | RENAUD REAL H | Corp. Executive VP | Payment of Exercise | F | 26.30 | 616 | 16,201 | 61,012 | 61.6 K to 61 K (-1.00 %) |
| Feb 24 2009 | CRL | CHARLES RIVER LABO ... | JOHST DAVID P | Corp Executive VP | Payment of Exercise | F | 26.30 | 822 | 21,619 | 60,614 | 61.4 K to 60.6 K (-1.34 %) |
| Feb 24 2009 | CRL | CHARLES RIVER LABO ... | BERTHOUX CHRISTOPHER | Executive Vice Pres ... | Payment of Exercise | F | 26.30 | 231 | 6,075 | 15,918 | 16.1 K to 15.9 K (-1.43 %) |
| Feb 24 2009 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Payment of Exercise | F | 26.30 | 3,106 | 81,688 | 237,915 | 241 K to 237.9 K (-1.29 %) |
| Feb 24 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 26.30 | 886 | 23,302 | 70,928 | 71.8 K to 70.9 K (-1.23 %) |
| Oct 03 2008 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 55.34 | 1,000 | 55,340 | 27,773 | 28.8 K to 27.8 K (-3.48 %) |
| Nov 19 2008 | CRL | CHARLES RIVER LABO ... | CHANG NANCY T | Director | Grant | A | 23.86 | 10,500 | 250,529 | 25,500 | 15 K to 25.5 K (+70.00 %) |
| Nov 05 2008 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Option Exercise | A | 35.90 | 8,500 | 305,150 | 8,500 | |
| Nov 05 2008 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Option Exercise | M | 43.07 | 3,000 | 129,210 | 0 | |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.33 | 300 | 16,599 | 6,400 | 6.7 K to 6.4 K (-4.48 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.32 | 200 | 11,064 | 6,700 | 6.9 K to 6.7 K (-2.90 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.31 | 100 | 5,531 | 6,900 | 7 K to 6.9 K (-1.43 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.22 | 300 | 16,566 | 7,000 | 7.3 K to 7 K (-4.11 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.09 | 200 | 11,018 | 7,300 | 7.5 K to 7.3 K (-2.67 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.08 | 100 | 5,508 | 7,500 | 7.6 K to 7.5 K (-1.32 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.00 | 300 | 16,500 | 7,600 | 7.9 K to 7.6 K (-3.80 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 55.00 | 900 | 49,500 | 7,900 | 8.8 K to 7.9 K (-10.23 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 54.91 | 300 | 16,473 | 8,800 | 9.1 K to 8.8 K (-3.30 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Sell | S | 54.84 | 300 | 16,452 | 9,100 | 9.4 K to 9.1 K (-3.19 %) |
| Oct 02 2008 | CRL | CHARLES RIVER LABO ... | THIER SAMUEL O MD | Director | Buy | M | 43.07 | 3,000 | 129,210 | 9,400 | 6.4 K to 9.4 K (+46.88 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.30 | 322 | 19,417 | 230,899 | 231.2 K to 230.9 K (-0.14 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.27 | 600 | 36,162 | 231,221 | 231.8 K to 231.2 K (-0.26 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.25 | 100 | 6,025 | 231,821 | 231.9 K to 231.8 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.15 | 200 | 12,029 | 231,921 | 232.1 K to 231.9 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.14 | 584 | 35,122 | 232,121 | 232.7 K to 232.1 K (-0.25 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.13 | 125 | 7,516 | 232,705 | 232.8 K to 232.7 K (-0.05 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.13 | 191 | 11,485 | 232,830 | 233 K to 232.8 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.34 | 200 | 12,068 | 233,021 | 233.2 K to 233 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.32 | 200 | 12,064 | 233,221 | 233.4 K to 233.2 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.31 | 600 | 36,186 | 233,421 | 234 K to 233.4 K (-0.26 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.30 | 100 | 6,030 | 234,021 | 234.1 K to 234 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.29 | 200 | 12,058 | 234,121 | 234.3 K to 234.1 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.27 | 605 | 36,463 | 234,321 | 234.9 K to 234.3 K (-0.26 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.26 | 200 | 12,052 | 234,926 | 235.1 K to 234.9 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.24 | 300 | 18,072 | 235,126 | 235.4 K to 235.1 K (-0.13 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.23 | 100 | 6,023 | 235,426 | 235.5 K to 235.4 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.20 | 495 | 29,799 | 235,526 | 236 K to 235.5 K (-0.21 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.19 | 800 | 48,152 | 236,021 | 236.8 K to 236 K (-0.34 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.18 | 200 | 12,036 | 236,821 | 237 K to 236.8 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.16 | 100 | 6,016 | 237,021 | 237.1 K to 237 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.15 | 100 | 6,015 | 237,121 | 237.2 K to 237.1 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.14 | 269 | 16,176 | 237,221 | 237.5 K to 237.2 K (-0.11 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.13 | 1,400 | 84,182 | 237,490 | 238.9 K to 237.5 K (-0.59 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.12 | 200 | 12,024 | 238,890 | 239.1 K to 238.9 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.11 | 600 | 36,066 | 239,090 | 239.7 K to 239.1 K (-0.25 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Option Exercise | M | 31.97 | 20,000 | 639,400 | 40,000 | |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Buy | M | 31.97 | 20,000 | 639,400 | 241,021 | 221 K to 241 K (+9.05 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 61.15 | 3,000 | 183,450 | 221,021 | 224 K to 221 K (-1.34 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.73 | 200 | 12,146 | 224,021 | 224.2 K to 224 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.72 | 200 | 12,144 | 224,221 | 224.4 K to 224.2 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.68 | 600 | 36,408 | 224,421 | 225 K to 224.4 K (-0.27 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.67 | 200 | 12,134 | 225,021 | 225.2 K to 225 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.60 | 113 | 6,848 | 225,221 | 225.3 K to 225.2 K (-0.05 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.59 | 1,100 | 66,649 | 225,334 | 226.4 K to 225.3 K (-0.49 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.59 | 587 | 35,566 | 226,434 | 227 K to 226.4 K (-0.26 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.42 | 813 | 49,121 | 227,021 | 227.8 K to 227 K (-0.36 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.40 | 1,765 | 106,606 | 227,834 | 229.6 K to 227.8 K (-0.77 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.35 | 900 | 54,315 | 229,599 | 230.5 K to 229.6 K (-0.39 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.34 | 200 | 12,068 | 230,499 | 230.7 K to 230.5 K (-0.09 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.32 | 200 | 12,064 | 230,699 | 230.9 K to 230.7 K (-0.09 %) |
| Aug 28 2008 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 65.70 | 1,000 | 65,700 | 28,773 | 29.8 K to 28.8 K (-3.36 %) |
| Aug 28 2008 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 65.75 | 900 | 59,175 | 29,773 | 30.7 K to 29.8 K (-2.93 %) |
| Aug 28 2008 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 65.76 | 100 | 6,576 | 30,673 | 30.8 K to 30.7 K (-0.32 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.11 | 400 | 24,044 | 239,690 | 240.1 K to 239.7 K (-0.17 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.09 | 203 | 12,198 | 240,090 | 240.3 K to 240.1 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.08 | 100 | 6,008 | 240,293 | 240.4 K to 240.3 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.07 | 200 | 12,014 | 240,393 | 240.6 K to 240.4 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.06 | 1,100 | 66,066 | 240,593 | 241.7 K to 240.6 K (-0.46 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.04 | 128 | 7,685 | 241,693 | 241.8 K to 241.7 K (-0.05 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 60.04 | 200 | 12,008 | 241,821 | 242 K to 241.8 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.99 | 316 | 18,957 | 242,021 | 242.3 K to 242 K (-0.13 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.98 | 400 | 23,992 | 242,337 | 242.7 K to 242.3 K (-0.16 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.97 | 495 | 29,685 | 242,737 | 243.2 K to 242.7 K (-0.20 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.96 | 300 | 17,988 | 243,232 | 243.5 K to 243.2 K (-0.12 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.95 | 200 | 11,990 | 243,532 | 243.7 K to 243.5 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.94 | 100 | 5,994 | 243,732 | 243.8 K to 243.7 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.93 | 200 | 11,986 | 243,832 | 244 K to 243.8 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.92 | 700 | 41,944 | 244,032 | 244.7 K to 244 K (-0.29 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.91 | 500 | 29,955 | 244,732 | 245.2 K to 244.7 K (-0.20 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.91 | 584 | 34,987 | 245,232 | 245.8 K to 245.2 K (-0.24 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.90 | 200 | 11,980 | 245,816 | 246 K to 245.8 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.88 | 200 | 11,976 | 246,016 | 246.2 K to 246 K (-0.08 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.87 | 400 | 23,948 | 246,216 | 246.6 K to 246.2 K (-0.16 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.87 | 1,405 | 84,117 | 246,616 | 248 K to 246.6 K (-0.57 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.78 | 1,000 | 59,780 | 248,021 | 249 K to 248 K (-0.40 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.77 | 500 | 29,885 | 249,021 | 249.5 K to 249 K (-0.20 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.73 | 100 | 5,973 | 249,521 | 249.6 K to 249.5 K (-0.04 %) |
| Sep 24 2008 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | President and CEO | Sell | S | 59.70 | 1,400 | 83,580 | 249,621 | 251 K to 249.6 K (-0.56 %) |
| Aug 19 2008 | CRL | CHARLES RIVER LABO ... | RENAUD REAL H | Corp. Executive VP | Option Exercise | M | 32.87 | 15,000 | 493,050 | 25,400 | |
| Aug 19 2008 | CRL | CHARLES RIVER LABO ... | RENAUD REAL H | Corp. Executive VP | Sell | S | 68.00 | 15,000 | 1,020,000 | 63,586 | 78.6 K to 63.6 K (-19.09 %) |
| Aug 19 2008 | CRL | CHARLES RIVER LABO ... | RENAUD REAL H | Corp. Executive VP | Buy | M | 32.87 | 15,000 | 493,050 | 78,586 | 63.6 K to 78.6 K (+23.59 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.25 | 162 | 10,895 | 71,814 | 72 K to 71.8 K (-0.23 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.79 | 125 | 8,474 | 71,976 | 72.1 K to 72 K (-0.17 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.70 | 50 | 3,385 | 72,101 | 72.2 K to 72.1 K (-0.07 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.53 | 112 | 7,563 | 72,151 | 72.3 K to 72.2 K (-0.15 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.50 | 150 | 10,125 | 72,263 | 72.4 K to 72.3 K (-0.21 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.48 | 50 | 3,374 | 72,413 | 72.5 K to 72.4 K (-0.07 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.30 | 163 | 10,970 | 72,463 | 72.6 K to 72.5 K (-0.22 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.85 | 62 | 4,207 | 72,626 | 72.7 K to 72.6 K (-0.09 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.84 | 100 | 6,784 | 72,688 | 72.8 K to 72.7 K (-0.14 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.77 | 163 | 11,046 | 72,788 | 73 K to 72.8 K (-0.22 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.74 | 162 | 10,974 | 72,951 | 73.1 K to 73 K (-0.22 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.69 | 163 | 11,033 | 73,113 | 73.3 K to 73.1 K (-0.22 %) |
| Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.66 | 162 | 10,961 | 73,276 | 73.4 K to 73.3 K (-0.22 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | RENAUD REAL H | Corp. Executive VP | Payment of Exercise | F | 66.05 | 1,164 | 76,882 | 63,586 | 64.8 K to 63.6 K (-1.80 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Option Exercise | M | 38.03 | 7,700 | 292,831 | 15,400 | |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.35 | 207 | 13,734 | 50,373 | 50.6 K to 50.4 K (-0.41 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.61 | 209 | 13,922 | 50,580 | 50.8 K to 50.6 K (-0.41 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.60 | 106 | 7,060 | 50,789 | 50.9 K to 50.8 K (-0.21 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.59 | 207 | 13,784 | 50,895 | 51.1 K to 50.9 K (-0.41 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.57 | 207 | 13,780 | 51,102 | 51.3 K to 51.1 K (-0.40 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.55 | 206 | 13,709 | 51,309 | 51.5 K to 51.3 K (-0.40 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.54 | 208 | 13,840 | 51,515 | 51.7 K to 51.5 K (-0.40 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.54 | 208 | 13,840 | 51,723 | 51.9 K to 51.7 K (-0.40 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.51 | 208 | 13,834 | 51,931 | 52.1 K to 51.9 K (-0.40 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.48 | 100 | 6,648 | 52,139 | 52.2 K to 52.1 K (-0.19 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 66.29 | 207 | 13,722 | 52,239 | 52.4 K to 52.2 K (-0.39 %) |
| Aug 13 2008 | CRL | CHARLES RIVER LABO ... | GILLETT NANCY | Corporate Executive ... | Sell | S | 65.70 | 2,000 | 131,400 | 52,446 | 54.4 K to 52.4 K (-3.67 %) |